2-Methoxyestradiol: New perspectives in colon carcinoma treatment

Molecular and Cellular Endocrinology

Volumn 331, Issue 1, 2011, Pages 119-128

  Parks, Michele ^a   Tillhon, Micol ^a   Donà, Francesca ^a   Prosperi, Ennio ^a   Scovassi, A Ivana ^a  

^a CNR   (Italy)

Author keywords

2 Methoxyestradiol; Apoptosis; Autophagy; Cell cycle; Colon carcinoma cells

Indexed keywords

2 METHOXYESTRADIOL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CARCINOMA CELL; CELL ADHESION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL CYCLE; CELL LINE, TUMOR; CELL SHAPE; CELL SURVIVAL; COLONIC NEOPLASMS; DNA FRAGMENTATION; ESTRADIOL; HISTONES; HUMANS; MITOCHONDRIA; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR STEM CELL ASSAY;

EID: 78149406276     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.08.017     Document Type: Article

References (68)

1. Attalla H., Westberg J.A., Andersson L.C., Adlercreutz H., Mäkelä T.P. 2-Methoxyestradiol-induced phosphorylation of bcl-2: uncoupling from jnk/sapk activation. Biochem. Biophys. Res. Commun. 1998, 247:616-619.
2. Basu A., Haldar S. 2-Methoxyestradiol mediated signaling network in pancreatic cancer. Front. Biosci. 2009, 14:2170-2180.
3. Bhati R., Gökmen-Polar Y., Sledge G.W., Fan C., Nakshatri H., Ketelsen D., Borchers C.H., Dial M.J., Patterson C., Klauber-DeMore N. 2-Methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells. Cancer Res. 2007, 67:702-708.
4. Bottone M.G., Soldani C., Tognon G., Gorrini C., Lazzè M.C., Brison O., Ciomei M., Pellicciari C., Scovassi A.I. Multiple effects of paclitaxel are modulated by a high c-myc amplification level. Exp. Cell Res. 2003, 15:49-59.
5. Bu S., Blaukat A., Fu X., Heldin N.E., Landström M. Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett. 2002, 531:141-151.
6. Carothers A.M., Hughes S.A., Ortega D., Bertagnolli M.M. 2-Methoxyestradiol induces p53-associated apoptosis of colorectal cancer cells. Cancer Lett. 2002, 187:77-86.
7. Cazzalini O., Scovassi A.I., Savio M., Stivala L.A., Prosperi E. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat. Res. 2010, 704:12-20.
8. Chen Y., McMillan-Ward E., Kong J., Israels S.J., Gibson S.B. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 2008, 15:171-182.
9. Dahut W.L., Lakhani N.J., Gulley J.L., Arlen P.M., Kohn E.C., Kotz H., McNally D., Parr A., Nguyen D., Yang S.X., Steinberg S.M., Venitz J., Sparreboom A., Figg W.D. Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors. Cancer Biol. Ther. 2006, 5:22-27.
10. Dikic I., Johansen T., Kirkin V. Selective autophagy in cancer development and therapy. Cancer Res. 2010, 70:3431-3434.
11. Dobos J., Tímár J., Bocsi J., Burián Z., Nagy K., Barna G., Peták I., Ladányi A. In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma. Int. J. Cancer 2004, 112:771-776.
12. Donà F., Prosperi E., Savio M., Coppa T., Scovassi A.I., Mondello C. Loss of histone H2AX increases sensitivity of immortalized mouse fibroblasts to the topoisomerase II inhibitor etoposide. Int. J. Oncol. 2008, 33:613-622.
13. Donzelli M., Bernardi R., Negri C., Prosperi E., Padovan L., Lavialle C., Brison O., Scovassi A.I. Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene. Oncogene 1999, 18:439-448.
14. Du B., Li Y., Li X., A Y., Chen C., Zhang Z. Preparation, characterization and in vivo evaluation of 2-methoxyestradiol-loaded liposomes. Int. J. Pharm. 2010, 384:140-147.
15. Dubey R.K., Jackson E.K. Potential vascular actions of 2-methoxyestradiol. Trends Endocrinol. Metab. 2009, 20:374-379.
16. Fotsis T., Zhang Y., Pepper M.S., Adlercreutz H., Montesano R., Nawroth P.P., Schweigerer L. The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumour growth. Nature 1994, 368:237-239.
17. Fulda S., Galluzzi L., Kroemer G. Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discov. 2010, 9:447-464.
18. Fukui M., Zhu B.T. Mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in human breast cancer cells. Mol. Carcinog. 2009, 48:66-78.
19. Gao N., Rahmani M., Dent P., Grant S. 2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process. Oncogene 2005, 24:3797-3809.
20. Giansanti V., Scovassi A.I. Apoptosis and cancer. Multiple pathways in cancer development 2008, 135-147. Transworld Research Network, Kerala, India. C. Mondello (Ed.).
21. Giansanti V., Camboni T., Piscitelli F., Prosperi E., La Regina G., Lazzè M.C., Santin G., Silvestri R., Scovassi A.I. Study of the effects of a new pyrazolecarboxamide: changes in mitochondria and induction of apoptosis. Int. J. Biochem. Cell Biol. 2009, 41:1890-1898.
22. Giansanti V., Piscitelli F., Camboni T., Prosperi E., La Regina G., Parks M., Silvestri S., Scovassi A.I. Arylthioindoles: promising compounds against cancer cell proliferation. Oncol. Lett. 2010, 1:109-112.
23. Glick D., Barth S., Macleod K.F. Autophagy: cellular and molecular mechanisms. J. Pathol. 2010, 221:3-12.
24. Golab J., Nowis D., Skrzycki M., Czeczot H., Baranczyk-Kuzma A., Wilczynski G.M., Makowski M., Mroz P., Kozar K., Kaminski R., Salili A., Kopec' M., Grzela T., Jakobisiak M. Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor. J. Biol. Chem. 2003, 278:407-414.
25. Gorrini C., Donzelli M., Torriglia A., Supino R., Brison O., Bernardi R., Negri C., Denegri M., Counis M.F., Ranzani G.N., Scovassi A.I. Effect of apoptogenic stimuli on colon carcinoma cell lines with a different c-myc expression level. Int. J. Mol. Med. 2003, 11:737-742.
26. Harrison M.R., Hahn N.M., Pili R., Oh W.K., Hammers H., Sweeney C., Kim K., Perlman S., Arnott J., Sidor C., Wilding G., Liu G. A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal(R) dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Invest. New Drugs 2010, 10.1007/s10637-010-9455-x.
27. Huang P., Feng L., Oldham E.A., Keating M.J., Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000, 407:390-395.
28. Kamath K., Okouneva T., Larson G., Panda D., Wilson L., Jordan M.A. 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules. Mol. Cancer. Ther. 2006, 5:2225-2233.
29. Kar S., Wang M., Carr B.I. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis. Cancer Chemother. Pharmacol. 2008, 62:831-840.
30. Kato S., Sadarangani A., Lange S., Delpiano A.M., Vargas M., Brañes J., Carvajal J., Lipkowitz S., Owen G.I., Cuello M.A. 2-Methoxyestradiol mediates apoptosis through caspase-dependent and independent mechanisms in ovarian cancer cells but not in normal counterparts. Reprod. Sci. 2008, 15:878-894.
31. Kirches E., Warich-Kirches M. 2-methoxyestradiol as a potential cytostatic drug in gliomas?. Anticancer Agents Med. Chem. 2009, 9:55-65.
32. Kumar A.P., Garcia G.E., Slaga T.J. 2-Methoxyestradiol blocks cell-cycle progression at G2/M phase and inhibits growth of human prostate cancer cells. Mol. Carcinog. 2001, 31:111-124.
33. Lakhani N.J., Sparreboom A., Xu X., Veenstra T.D., Venitz J., Dahut W.L., Figg W.D. Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol. J. Pharm. Sci. 2007, 96:1821-1831.
34. Lambert C., Apel K., Biesalski H.K., Frank J. 2-Methoxyestradiol induces caspase-independent, mitochondria-centered apoptosis in DS-sarcoma cells. Int. J. Cancer. 2004, 108:493-501.
35. LaVallee T.M., Zhan X.H., Johnson M.S., Herbstritt C.J., Swartz G., Williams M.S., Hembrough W.A., Green S.J., Pribluda V.S. 2-Methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. Cancer Res. 2003, 63:468-475.
36. Li L., Bu S., Bäckström T., Landström M., Ulmsten U., Fu X. Induction of apoptosis and G2/M arrest by 2-Methoxyestradiol in human cervical cancer HeLaS3 cells. Anticancer Res. 2004, 24:873-880.
37. Lin H.L., Liu T.Y., Wu C.W., Chi C.W. 2-Methoxyestradiol-induced caspase-3 activation and apoptosis occurs through G2/M arrest dependent and independent pathways in gastric carcinoma cells. Cancer 2001, 92:500-509.
38. Lorin S., Borges A., Ribeiro Dos Santos L., Souquère S., Pierron G., Ryan K.M., Codogno P., Djavaheri-Mergny M. c-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells. Cancer Res. 2009, 69:6924-6931.
39. Lorin S., Pierron G., Ryan K.M., Codogno P., Djavaheri-Mergny M. Evidence for the interplay between JNK and p53-DRAM signalling pathways in the regulation of autophagy. Autophagy 2010, 6:153-154.
40. Mabjeesh N.J., Escuin D., LaVallee T.M., Pribluda V.S., Swartz G.M., Johnson M.S., Willard M.T., Zhong H., Simons J.W., Giannakakou P. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003, 3:363-375.
41. Majer M., Akerley W., Kuwada S.K. Oncologists' current opinion on the treatment of colon carcinoma. Anticancer Agents Med. Chem. 2007, 7:492-503.
42. Maran A., Shogren K.L., Benedikt M., Sarkar G., Turner R.T., Yaszemski M.J. 2-methoxyestradiol-induced cell death in osteosarcoma cells is preceded by cell cycle arrest. J. Cell. Biochem. 2008, 104:1937-1945.
43. Matthews J., Gustafsson J.A. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol. Interv. 2003, 5:281-292.
44. Mooberry S.L. Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist. Updat. 2003, 6:355-361.
45. Moreau K., Luo S., Rubinsztein D.C. Cytoprotective roles for autophagy. Curr. Opin. Cell Biol. 2010, 22:206-211.
46. Mueck A.O., Seeger H. 2-Methoxyestradiol-Biology and mechanism of action. Steroids 2010, 75:625-631.
47. Pasquier E., Sinnappan S., Munoz M.A., Kavallaris M. ENMD-1198, a new analogue of 2-methoxyestradiol, displays both antiangiogenic and vascular-disrupting properties. Mol. Cancer Ther. 2010, 9:1408-1418.
48. Pribluda V.S., Gubish E.R., LaVallee T.M., Treston A., Swartz G.M., Green S.J. 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev. 2000, 19:173-179.
49. Qanungo S., Basu A., Das M., Haldar S. 2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene 2002, 21:4149-4157.
50. Qadan L.R., Perez-Stable C.M., Anderson C., D'Ippolito G., Herron A., Howard G.A., Roos B.A. 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer. Biochem. Biophys. Res. Commun. 2001, 285:1259-1266.
51. Schumacher G., Neuhaus P. The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors. J. Cancer Res. Clin. Oncol. 2001, 127:405-410.
52. Seegers J.C., Lottering M.L., Grobler C.J.S., Papendorp D.H.V., Habbersett R.C., Shou Y., Lehnert B.E. The mammalian metabolite, 2-Methoxyestradiol, affects P53 levels and apoptosis induction in transformed cells but not in normal cells. J. Steroid. Biochem. Mol. Biol. 1997, 62:253-267.
53. Shimada K., Nakamura M., Ishida E., Kishi M., Konishi N. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis 2003, 24:1067-1075.
54. Shimada K., Nakamura M., Ishida E., Kishi M., Matsuyoshi S., Konishi N. The molecular mechanism of sensitization to Fas-mediated apoptosis by 2-methoxyestradiol in PC3 prostate cancer cells. Mol. Carcinog. 2004, 39:1-9.
55. Soldani C., Scovassi A.I. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 2002, 7:321-328.
56. Stander B.A., Marais S., Vorster C.J., Joubert A.M. In vitro effects of 2-methoxyestradiol on morphology, cell cycle progression, cell death and gene expression changes in the tumorigenic MCF-7 breast epithelial cell line. J. Steroid Biochem. Mol. Biol. 2010, 119:149-160.
57. Sutherland T.E., Anderson R.L., Hughes R.A., Altmann E., Schuliga M., Ziogas J., Stewart A.G. 2-Methoxyestradiol-a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents. Drug Discov. Today 2007, 12:577-584.
58. Sweeney C., Liu G., Yiannoutsos C., Kolesar J., Horvath D., Staab M.J., Fife K., Armstrong V., Treston A., Sidor C., Wilding G. A Phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-Methoxyestradiol capsules in hormone-refractory prostate cancer. Clin. Cancer. Res. 2005, 11:6625-6633.
59. Tevaarwerk A.J., Holen K.D., Alberti D.B., Sidor C., Arnott J., Quon C., Wilding G., Liu G. Phase I trial of 2-Methoxyestradiol nanocrystal dispersion in advanced solid malignancies. Clin. Cancer. Res. 2009, 15:1460-1465.
60. Thaver V., Lottering M.L., Papendorp D.V., Joubert A. In vitro effects of 2-methoxyestradiol on cell numbers, morphology, cell cycle progression, and apoptosis induction in oesophageal carcinoma cells. Cell. Biochem. Funct. 2009, 27:205-210.
61. Ting C.M., Lee Y.M., Wong C.K., Wong A.S., Lung H.L., Lung M.L., Lo K.W., Wong R.N., Mak N.K. 2-Methoxyestradiol induces endoreduplication through the induction of mitochondrial oxidative stress and the activation of MAPK signaling pathways. Biochem. Pharmacol. 2010, 79:825-841.
62. Torriglia A., Negri C., Chaudun E., Prosperi E., Courtois Y., Counis M.F., Scovassi A.I. Differential involvement of DNase II in HeLa cell apoptosis induced by etoposide and long term culture. Cell Death Differ. 1999, 6:234-244.
63. Van Zijl C., Lottering M.L., Steffens F., Joubert A. In vitro effects of 2-methoxyestradiol on MCF-12A and MCF-7 cell growth, morphology and mitotic spindle formation. Cell Biochem. Funct. 2008, 26:632-642.
64. Wang S.H., Shi X., Chen X., Baker J.R. Therapeutic efficacy of 2-Methoxyestradiol microcrystals encapsulated within polyelectrolyte multilayers. Macromol. Biosci. 2009, 9:429-436.
65. Wood L., Leese M.R., Leblond B., Woo L.W., Ganeshapillai D., Purohit A., Reed M.J., Potter B.V., Packham G. Inhibition of superoxide dismutase by 2-methoxyoestradiol analogues and oestrogen derivatives: structure-activity relationships. Anticancer Drug Des. 2001, 16:209-215.
66. Yue T.L., Wang X., Louden C.S., Gupta S., Pullarisetti K., Gu J.L., Hart T.K., Lysko P.G., Feuerstein G.Z. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression. Mol. Pharmacol. 1997, 51:951-962.
67. Zhou Q., Gustafson D., Nallapareddy S., Diab S., Leong S., Lewis K., Gore L., Messersmith W.A., Treston A.M., Eckhardt S.G., Sidor C., Camidge D.R. A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer. Invest. New Drugs 2010, 10.1007/s10637-009-9383-9.
68. Zou H.C., Adachi M., Imai K., Hareyama M., Yoshioka K., Zhao S., Shinomura Y. 2-Methoxyestradiol, an endogenous mammalian metabolite, radiosensitizes colon carcinoma cells through c-Jun NH2-terminal kinase activation. Clin. Cancer. Res. 2006, 12:6532-6539.